The association of race/ethnicity and risk of atypical femur fracture among older women receiving oral bisphosphonate therapy
- 1 April 2016
- journal article
- Published by Elsevier BV in Bone
- Vol. 85, 142-147
- https://doi.org/10.1016/j.bone.2016.01.002
Abstract
No abstract availableKeywords
Funding Information
- Kaiser Permanente
- National Institutes of Health (1R01AG047230-01 A1)
This publication has 20 references indexed in Scilit:
- Risk of atypical femoral fracture during and after bisphosphonate useActa Orthopaedica, 2015
- Femoral shaft strains during daily activities: Implications for atypical femoral fracturesClinical Biomechanics, 2014
- Review: Epidemiology and Pathophysiology of Atypical Femur FracturesCurrent Osteoporosis Reports, 2014
- Are Race and Sex Associated With the Occurrence of Atypical Femoral Fractures?Clinical Orthopaedics and Related Research, 2013
- Proposed pathogenesis for atypical femoral fractures: Lessons from materials researchBone, 2013
- Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral ResearchJournal of Bone and Mineral Research, 2013
- Atypical Femoral Fractures: What Do We Know About Them?Journal of Bone and Joint Surgery, 2013
- Japanese 2011 guidelines for prevention and treatment of osteoporosis—executive summaryArchives of Osteoporosis, 2012
- Distribution of atypical fractures and cortical stress lesions in the femur: implications on pathophysiology.2011
- Low-Energy Femoral Shaft Fractures Associated With Alendronate UseJournal of Orthopaedic Trauma, 2008